Results 41 to 50 of about 1,900 (208)
The North American toxic fungal pathogen G3 Claviceps purpurea (Fries) Tulasne is established in the German Wadden Sea. [PDF]
, 2012 Three lineages (G1, G2 and G3) within the toxic invasive ergot fungus Claviceps purpurea (Fries) Tulasne are known; these should be recognized as unique species, or at least as varieties.
Boestfleisch, Christian +3 more
core +1 more source
RFWD3 Reprograms Nucleotide Metabolism Through PHGDH to Induce Chemoresistance In Osteosarcoma
Advanced Science, Volume 12, Issue 16, April 24, 2025.RFWD3 is identified as a key regulator of cisplatin (DDP) sensitivity in osteosarcoma using a genome‐wide CRISPR screen. RFWD3 promotes PHGDH ubiquitination, enhancing NAD+‐mediated nucleotide biosynthesis. Knocking out RFWD3 sensitized osteosarcoma cells to DDP.
Wenchao Zhang +6 more
wiley +1 more source
Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study [PDF]
, 2018 ObjectiveTo evaluate long-term predictors of remission in patients with medication-overuse headache (MOH) by prospective cohort study.BackgroundKnowledge regarding long-term predictors of MOH outcome is limited.MethodsTwo hundred and forty MOH patients ...
Jovanovic, Zagorka +6 more
core +3 more sources
Do antithrombotic drugs have a role in migraine prevention? A systematic review
Headache: The Journal of Head and Face Pain, Volume 65, Issue 4, Page 709-727, April 2025.Abstract Objectives To explore the available evidence on the role of antithrombotics as migraine preventive medication. Background In clinical practice, the use of antithrombotic drugs in individuals with migraine is sometimes considered, especially in the case of frequent auras, association with patent foramen ovale, or prothrombotic states.
Federico De Santis +7 more
wiley +1 more source
Headache: The Journal of Head and Face Pain, Volume 65, Issue 4, Page 589-607, April 2025.Abstract Objective To estimate rates of migraine progression and assess predictors of progression in a large, longitudinal cohort study using the traditional definition and two alternative definitions of migraine progression. Background Traditionally, migraine progression is defined as moving from episodic migraine (EM) with ≤ 14 monthly headache days (
Dawn C. Buse +8 more
wiley +1 more source
Does Onabotulinumtoxin-a Decrease Frequency of Headaches in Adults with Chronic Migraines? [PDF]
, 2020 Objective: The objective of this selective EBM review is to determine whether or not onabotulinumtoxin-A decreases the frequency of headaches in adults with chronic migraines.
Bouikidis, Evangela
core +1 more source
Is Vitamin D an Effective Add-on Therapy for Decreasing Migraine Frequency in Adults? [PDF]
, 2023 Objective: The objective of this selective EBM review is to determine “Is Vitamin D an effective add-on Therapy for Decreasing Migraine Frequency in Adults” Study Design: A review of two randomized controlled trials and a placebo-controlled double-blind ...
Conway, Jazmin
core +1 more source
Headache: The Journal of Head and Face Pain, Volume 65, Issue 1, Page 68-79, January 2025.Abstract Objective To assess changes in real‐world use of acute and preventive medications for migraine over a 12‐month follow‐up period in the United States following initiation of the anti‐calcitonin gene‐related peptide (CGRP) pathway monoclonal antibody (mAb) erenumab.
Jasjit K. Multani +10 more
wiley +1 more source
Does non-invasive vagal nerve stimulation (nVNS) improve migraine headaches in adult patients? [PDF]
, 2023 OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Does non-invasive vagal nerve stimulation (nVNS) improve migraine headaches in adult patients?” STUDY DESIGN: A systematic review of three randomized controlled trials (
Heard, Gavin T.
core +1 more source